Knightsbridge Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Knightsbridge Asset Management's BMY Position: Q2 2026 in Review
Knightsbridge Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 29% in Q2 2026, selling an estimated $280K and leaving 11,934 shares worth $688K. The position accounts for 0.09% of the portfolio, ranked #109.
Knightsbridge Asset Management first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.02M in Q1 2026. 2,516 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Knightsbridge Asset Management held 11,934 shares of Bristol-Myers Squibb worth $688K as of Q2 2026.
- Knightsbridge Asset Management sold 4,875 Bristol-Myers Squibb shares in Q2 2026, an estimated $280K.
- Bristol-Myers Squibb made up 0.09% of Knightsbridge Asset Management's portfolio in Q2 2026, its #109 holding.
- Knightsbridge Asset Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Knightsbridge Asset Management's Bristol-Myers Squibb position peaked at $1.02M in Q1 2026.
- 2,516 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Knightsbridge Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.